Search Count: 32
![]() |
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: RNA BINDING PROTEIN/RNA |
![]() |
Staphylococcus Epidermidis Rp62A Crispr Effector Subcomplex With Non-Self Target Rna Bound
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA |
![]() |
Staphylococcus Epidermidis Rp62A Crispr Effector Complex With Non-Self Target Rna 2
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA |
![]() |
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA |
![]() |
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA Ligands: ATP |
![]() |
Staphylococcus Epidermidis Rp62A Crispr Short Effector Complex With Self Rna Target And Atp
Organism: Staphylococcus epidermidis, Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA Ligands: ATP |
![]() |
Organism: Staphylococcus epidermidis rp62a
Method: ELECTRON MICROSCOPY Release Date: 2022-07-06 Classification: HYDROLASE/RNA |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2017-10-18 Classification: DNA BINDING PROTEIN |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2016-11-09 Classification: PROTEIN BINDING |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2016-11-09 Classification: PROTEIN BINDING |
![]() |
Structure Of Wild-Type Igg1 Antibody Heavy Chain Constant Domain 1 And Light Chain Lambda Constant Domain (Igg1 Ch1:Clambda) At 1.19A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.19 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM |
![]() |
Structure Of Redesigned Igg1 First Constant And Lambda Domains (Ch1:Clambda Constant Redesign 1, Crd1) At 1.75A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM |
![]() |
Structure Of Redesigned Igg1 First Constant And Lambda Domains (Ch1:Clambda Constant Redesign 2 Beta, Crd2B) At 1.42A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: PG6 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: SO4, ACT |
![]() |
Crystal Structure Of Pertuzumab Clambda Fab With Variable Domain Redesign (Vrd2) At 1.95A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: SO4 |
![]() |
Crystal Structure Of Pertuzumab Clambda Fab With Variable And Constant Domain Redesigns (Vrd2 And Crd2) At 1.6A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: GOL, MG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-03-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0KK, TLA |
![]() |
Structure Of Bace Bound To 2-Imino-5-(3'-Methoxy-[1,1'-Biphenyl]-3-Yl)-3-Methyl-5-Phenylimidazolidin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2012-03-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0KM, TLA |
![]() |
Structure Of Bace Bound To 2-Imino-3-Methyl-5-Phenyl-5-(3-(Pyridin-3-Yl)Phenyl)Imidazolidin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2012-03-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0KP, TLA |
![]() |
Structure Of Bace Bound To 5-(3-(5-Chloropyridin-3-Yl)Phenyl)-5-Cyclopropyl-2-Imino-3-Methylimidazolidin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2012-03-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0KQ, TLA |